21 Jun 2016
The FEI has announced an adverse analytical finding involving prohibited substances.
Samples taken at the 80km CEI*1 in Amman (JOR) on 21 May 2016 from the second-placed horse Obama Al Aswad (FEI ID 104DF50, ridden by Nayef Al Fayez (FEI ID 10066952), have returned positive for the banned substance Boldenone, and the controlled medications Dexamethasone, Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone.
Boldenone, an anabolic steroid, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
The corticosteroid Dexamethasone is used to treat inflammatory and auto-immune conditions, while the non-steroidal anti-inflammatory drugs Meloxicam, Phenylbutazone and its metabolite Oxyphenbutazone are used for pain relief.
The athlete has been provisionally suspended from the date of notification (20 June 2016). The horse has also been provisionally suspended for a two-month period.
Further details on this case can be found here.
Endurance-world.com - Full Article 19 April 2018 Race Report made with the assistance of Clémence BAUDIN La Voulte sur Rhône. France. S...
The CI notation was later removed and does not now show up on the race stats Credit : Screen shot Grandprix-replay.com - Full Article ...
ItaliaEnduranceFestival.com 18/09/2017 - evento sportivo FEI MEYDAN Endurance Championship for athletes under 21 years of age; the cur...
Gulfnews.com - Full Article UAE riders sweep through Toscana Endurance event Published: 19:00 July 18, 2017 Gulf News Staff Report D...